4 results about "Anemone chinensis" patented technology

This invention belongs to the field of traditional Chinese medicine, specifically relating to a traditional Chinese medicine composition for treating low anterior rectal resection syndrome and its uses. By weight, the traditional Chinese medicine composition consists of 18-30 parts of Atractylodes macrocephala, 12-18 parts of Atractylodes lancea, 12-18 parts of Coix lacryma-jobi, 18-30 parts of Poria cocos, 12-20 parts of Galla chinensis, 12-16 parts of Scutellaria baicalensis, 20-30 parts of Paeonia lactiflora, 9-12 parts of Mentha haplocalyx, 9-18 parts of Astragalus membranaceus, 12-18 parts of Pulsatilla chinensis, 12-18 parts of Prunus mume, 12-18 parts of Cimicifuga foetida, 10-15 parts of Phellodendron chinense, and 10-16 parts of Paeonia lactiflora. These fourteen herbs work together to tonify the spleen and stomach, clear damp-heat, and astringe the intestines, and can be used to prepare a medicine for treating low anterior rectal resection syndrome.

This invention provides an application of Pulsatilla Decoction in the preparation of drugs for treating cognitive impairment. It significantly improves spatial learning and memory, recognition memory, and anxiety-depression-like behaviors in model mice, while increasing cerebral blood flow, reducing hippocampal neuronal damage, and effectively regulating the levels of neurotransmitters such as tryptophan, 5-HT, dopamine, and GABA in the brain. This formula exerts a central protective effect while alleviating intestinal inflammation, demonstrating the dual regulatory advantage of the gut-brain axis. Furthermore, its active ingredient, Pulsatilla saponin B4, also has the effect of improving cognitive function. This invention provides a scientific basis for the "repurposing" of classic formulas, possessing clear efficacy, good safety, and mature preparation technology, and has good prospects for clinical translation.

This application belongs to the technical field of traditional Chinese medicine compound formulas for poultry, and discloses a fermented traditional Chinese medicine compound, its preparation method, and its application. The fermented traditional Chinese medicine compound is obtained by fermenting a traditional Chinese medicine compound with Aspergillus niger. The traditional Chinese medicine compound comprises the following components by weight: 70-90 parts Coptis chinensis, 90-110 parts Scutellaria baicalensis, 110-130 parts Lonicera japonica, 90-110 parts Forsythia suspensa, 110-130 parts Pulsatilla chinensis, 90-110 parts Andrographis paniculata, 110-130 parts Taraxacum mongolicum, 70-90 parts Atractylodes lancea, 90-110 parts Atractylodes macrocephala, 90-110 parts Poria cocos, and 30-50 parts Glycyrrhiza uralensis. This application provides a fermented traditional Chinese medicine compound that, through fermentation with Aspergillus niger using a specific combination of traditional Chinese medicines, significantly improves the prevention and treatment efficacy of the traditional Chinese medicine combination against bacterial diseases in chickens.

The invention belongs to the field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine probiotic composition for preventing and treating colorectal cancer and application thereof. The traditional Chinese medicine probiotic composition is prepared from a traditional Chinese medicine composition and probiotics, the traditional Chinese medicine composition is prepared from the following raw materials in parts by mass: 15g of Chinese pulsatilla root, 12g of cortex fraxini, 12g of cortex phellodendri and 6g of rhizoma coptidis. The feed is characterized in that the probiotics are Bifidobacterium pseudolongum (B.p), and the preservation number of the probiotics is ATCC (American Type Culture Collection) 25526. The invention finds that the combined application of the Chinese pulsatilla root decoction compound and the bifidobacterium pseudolongum shows obvious synergistic and excellent effects in the aspect of inhibiting the colorectal cancer, which is superior to the single application of the traditional Chinese medicine compound or the probiotics, and the invention provides a novel, safe and effective traditional Chinese medicine and traditional Chinese medicine-probiotic combined intervention scheme for preventing and treating the colorectal cancer. Good application prospects are realized.